HomeCompareMBINP vs MRK

MBINP vs MRK: Dividend Comparison 2026

MBINP yields 6.99% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MBINP wins by $44460.85M in total portfolio value
10 years
MBINP
MBINP
● Live price
6.99%
Share price
$25.02
Annual div
$1.75
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44460.90M
Annual income
$43,272,405,382.86
Full MBINP calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MBINP vs MRK

📍 MBINP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMBINPMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MBINP + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MBINP pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MBINP
Annual income on $10K today (after 15% tax)
$594.52/yr
After 10yr DRIP, annual income (after tax)
$36,781,544,575.43/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MBINP beats the other by $36,781,536,247.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MBINP + MRK for your $10,000?

MBINP: 50%MRK: 50%
100% MRK50/50100% MBINP
Portfolio after 10yr
$22230.48M
Annual income
$21,636,207,590.50/yr
Blended yield
97.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MBINP
Analyst Ratings
1
Strong
4
Buy
1
Hold
Consensus: Buy
Altman Z
1.0
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MBINP buys
0
MRK buys
0
No recent congressional trades found for MBINP or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMBINPMRK
Forward yield6.99%2.76%
Annual dividend / share$1.75$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$44460.90M$56.8K
Annual income after 10y$43,272,405,382.86$9,798.13
Total dividends collected$44379.24M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: MBINP vs MRK ($10,000, DRIP)

YearMBINP PortfolioMBINP Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,099$1,398.88$11,206$366.19+$893.00MBINP
2$16,109$3,163.53$12,650$502.35+$3.5KMBINP
3$25,110$7,873.19$14,407$694.19+$10.7KMBINP
4$49,807$22,938.72$16,585$967.82+$33.2KMBINP
5$138,339$85,045.75$19,342$1,363.89+$119.0KMBINP
6$589,548$441,525.61$22,913$1,947.19+$566.6KMBINP
7$4,147,857$3,517,040.13$27,662$2,823.89+$4.12MMBINP
8$50,689,939$46,251,732.24$34,159$4,173.35+$50.66MMBINP
9$1,110,744,921$1,056,506,686.77$43,337$6,308.80+$1110.70MMBINP
10$44,460,902,449$43,272,405,382.86$56,776$9,798.13+$44460.85MMBINP

MBINP vs MRK: Complete Analysis 2026

MBINPStock

Merchants Bancorp operates as the diversified bank holding company in the United States. The company operates through Multi-family Mortgage Banking, Mortgage Warehousing, and Banking segments. The Multi-family Mortgage Banking segment originates and services government sponsored mortgages for multi-family and healthcare facilities. This segment also offers customized loan products for independent living, assisted living, memory care, and skilled nursing projects; and operates as a syndicator of low-income housing tax credit and debt funds. The Mortgage Warehousing segment funds agency eligible residential loans, including origination, purchase, and sale in the secondary market, as well as commercial loans to non-depository financial institutions. The Banking segment offers a range of financial products and services to consumers and businesses, such as various types of deposit products, as well as multi-family construction and bridge, commercial real estate, commercial and industrial, agricultural, residential mortgage, and consumer loan products. This segment also provides single-family mortgage lending; construction, bridge, and lot financing; first-lien home equity lines of credit; and small business administration lending products and services. Merchants Bancorp was founded in 1990 and is headquartered in Carmel, Indiana.

Full MBINP Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MBINP vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MBINP vs SCHDMBINP vs JEPIMBINP vs OMBINP vs KOMBINP vs MAINMBINP vs JNJMBINP vs ABBVMBINP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.